Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
8.46
-0.27 (-3.09%)
At close: Mar 28, 2025, 4:00 PM
8.52
+0.06 (0.69%)
After-hours: Mar 28, 2025, 7:50 PM EDT

Avalo Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Avalo Therapeutics stock have an average target of 34.33, with a low estimate of 23 and a high estimate of 48. The average target predicts an increase of 305.79% from the current stock price of 8.46.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $23 $34.33 $36 $48
Change +171.87% +305.79% +325.53% +467.38%

Analyst Ratings

The average analyst rating for Avalo Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 002224
Buy 111122
Hold 111111
Sell 000000
Strong Sell 000000
Total 224457

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Jefferies
Jefferies
Strong Buy
Initiates
$23
Strong Buy Initiates $23 +171.87% Mar 25, 2025
Stifel
Stifel
Strong Buy
Initiates
$36
Strong Buy Initiates $36 +325.53% Mar 25, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Mar 20, 2025
Piper Sandler
Piper Sandler
Buy
Initiates
$48
Buy Initiates $48 +467.38% Feb 28, 2025
BTIG
BTIG
Strong Buy
Initiates
$40
Strong Buy Initiates $40 +372.81% Dec 19, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 441.00K
Revenue Next Year
n/a
EPS This Year
-5.42
from -20.91
EPS Next Year
-4.39
from -5.42
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
6.70M5.40M18.05M1.92M441.00K---
Revenue Growth
-0.76%-19.42%234.40%-89.34%-77.08%---
EPS
-2,489.12-2,331.41-1,062.65-113.58-20.91-5.42-4.39-4.25
EPS Growth
--------
Forward PE
--------
No. Analysts -----664
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 2025202620282029
High -4.75 -1.60 -3.72
Avg -5.42 -4.39 -4.25
Low -6.40 -6.77 -4.69

EPS Growth

EPS Growth 2025202620282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.